Objective: To test the anticonvulsive potential of a range of repetitive transcranial magnetic stimulation (rTMS) frequencies by novel methods for simultaneous EEG and rTMS in a rat seizure model. Methods: Seizures were triggered by intraperitoneal kainic acid (KA; 10 mg/kg). Rats (n = 21) were divided into three groups in which individual seizures were treated with rTMS trains at one of three frequencies: 0.25, 0.5 or 0.75 Hz. EEG was continuously viewed by an operator who identified each seizure onset. Consecutive seizures in each animal were (1) treated with active rTMS, (2) treated with sham rTMS, or (3) were untreated. EEG was re-analyzed post hoc by visual inspection, and seizure durations were compared within and between treatment groups. Results: KA-induced seizures were abbreviated by 0.75 Hz (P = 0.019) and 0.5 Hz (P = 0.033) active EEGguided rTMS. In contrast, neither active 0.25 Hz rTMS nor the control conditions affected seizure duration (P > 0.2). Conclusions: We demonstrate that EEG-guided rTMS can suppress seizures in the rat KA epilepsy model, and that the effect is frequency dependent, with 0.75 and 0.5 Hz rTMS being superior to 0.25 Hz rTMS. Significance: These data support the use of rat seizure models in translational research aimed at evaluation and development of effective rTMS anticonvulsive protocols. We also offer a proof of principle that real-time analysis of EEG can be used to guide rTMS to suppress individual seizures.
Introduction
Transcranial magnetic stimulation (TMS) is a method for noninvasive focal cortical stimulation that is based on Faraday's principle of electromagnetic induction where small intracranial electrical currents are generated by a powerful fluctuating extracranial magnetic field (Barker et al., 1985; Kobayashi and Pascual-Leone, 2003) . In the recent years, TMS has emerged as a potential therapeutic tool in epilepsy (Theodore, 2003) . The widest use of TMS in epilepsy is based on the capacity of interictal prolonged trains of low frequency (61 Hz) repetitive TMS (rTMS) to induce a lasting reduction in cortical excitability, thereby raising seizure threshold and reducing seizure frequency (Theodore et al., 2002; Fregni et al., 2006; Santiago-Rodriguez et al., 2008) . The mechanisms for increasing seizure threshold by interictal rTMS are not completely characterized, but are likely similar to those of long-term depression (LTD) induced by electrical stimulation at low frequencies (Dudek and Bear, 1992; Kandel, 2001; Hallett, 2007) .
In addition to altering seizure threshold by interictal trains of low frequency rTMS, there is also the potential for ictal rTMS is to terminate ongoing individual seizures. For abortive seizure therapy, rTMS anticonvulsive mechanisms may relate more to its capacity to interrupt ongoing neuronal activity as for instance can be seen with functional impairment of cortical function in human subjects (Amassian et al., 1989; Cohen et al., 1997) . Ictal rTMS has been applied clinically in several cases of human epilepsia partialis continua (EPC), with seizures terminated in approximately half of the subjects (Graff-Guerrero et al., 2004; Misawa et al., 2005; Morales et al., 2005; Rotenberg et al., 2008) . However, interpretation of data from these few human trials is limited since a broad range of rTMS protocols were used with a small and heterogeneous population of patients. Thus, the differential effect of altering ictal rTMS paradigms has not been formally tested, and remains a gap in knowledge. 
